 |


ION CHANNEL and RECEPTOR LIGANDS TOXINS & ALKALOIDS

Anti-nicotinic and spasmolitic activity of Quinuclidine / Piperidine (PMP, TMP) derivates.
|
|
Products Code |
Ganglion blocking in cats, ED50 (mg/kg) |
Antgonism, guinea pigs ileum |
Upper cervical (nictiating membrane). |
Relaive potency |
Heart para sympathe- tic (vagus) |
Gluttonal2 |
[7]Arterial pressure drop, i.v. |
CNS activity1 |
DMPP parasymp.) IC50(µ/ml) |
ACh (µM/l) [5]3 |
Nicotine (5], (µg) |
BaCl2 (µM/l) [7] |
Histamine [5] |
Temechine L9044 | 0.017 [2] | - | ND | ND | + | ND | ND | ND | ND | ND | ND |
Pempidine L9043 | 0.106 [1] 0.054 [2] 10-20 µg/kg - n/act. 50 µg / kg - active 100 µg/kg - complete relaxation [5] | 1.19 [1] 1.35 [3] 2.5 [4 | 0.301 | 0.384 | + | 0.45 | 0.58 | 1 - slight potentiation >10 - anta- gonism | 100 µg of nicotine: 10 µg - 100% block | n/act. | n/act. |
Tempidine L9059 | 0.055[1] 10-20 µg/kg-n/act 50 µg/kg-active 100 µg/kg-complete relaxation[5] | 2.24 [1] 2.0 [3] 2.0 [4] | 0.128 | 0.186 | + | 0.26 | 0.26 | n/act. | 200 µg of nicotine: 60 µg - 100% block | n/act. | n/act. |
Pempidone L9067 | 100 µg/kg-active 200 µg/kg-complete relaxation, arterial pressure drop [5]. highly active [6] | ND | ND | ND | + | ND | ND | n/act. | 100 µg of nicotine: 20 µg - 100% block | ND | antag. |
Tempidone L9066 | - | - | - | - | 1 mg/kg 22% | - | - | - | ND | 0.1 31% 1 65% 10 74%
| n/act. upt o 80 µM [8] |
Tempoxime L9057 | highly active [6] | ND | ND | ND | 2 mg/kg 31% | ND | ND | - | ND | 0.1 31% 1 65% 10 74% | ND |
Nanophine L9042 | ND | n/act. [4] | ND | ND | ND | ND | ND | ND | ND | ND | ND |
| Mecamylamine | ND | 1.0 [4] | ND | ND | + | ND | ND | - | ND | ND | ND |
| Hexamethonium | 0.172 | 1.0[1.3] | n/act. | n/act. | + | 25.70 | 6.30 | - | ND | ND | ND |
1 Temechine and Pempidine as tosylates. Prevetion of tremor and convulsions in rabbits caused by nicotine (
0.6 mg/kg i.v., 5 min. before the substance). No central anti-muscarinic activity (mice, arecoline 15 mg/kg,s.c.), at 1-20
mg/kg increase in arecoline tremor, salivation and mortality. 2 No effect on muscarinic activity of ACh or direct electrical stimulation
(post-ganglionic innervation).
[1] Tichonenko V.M., Farm. Toksikol., 25(6):689-705 (1962) (Russ).
[2] Sharapov I.M., Farm. Toksikol., (6):687-690, (1972) (Russ).
[3] Bretheric L. et al., Nature(London),184:1707-09 (1959).
[4] Spinks A., Young E.H.P., Nature (London), 181:1397 (1958).
[5] Philippot E. et al., Arch. Int. Pharm. Ther., 135:(3-4):273-280 (1962).
[6] Vezen A.E. et al.,Dokl. Nauk Tadzh.SSR, 28 (6):350-351 (1985).
[7] Akhmedkhodzhaeva Kh.S. et al.,"Farmakol. Alkaloidov Ikh Proizvod.", 1972, p.156-162, Fan, Tashkent, USSR.
[8] Rojas Martinez R.L., Rev.Cubana Farm., 16:146-156 (1982).
|
|
|
To send your order or inquiry : latoxan@latoxan.com
Revised : 09/04/2002 13:48 - Copyright © Latoxan |
|
20, rue Léon Blum - 26000 VALENCE - FRANCE
Tél. : 04.75.41.91.91 - Fax. : 04.75.41.91.99
International Phone : +33.4.75.41.91.91 - Fax. : +33.4.75.41.91.99 |
|